A randomized, double-blind study with the sirolimus-eluting Bx-Velocity™ balloon expandable stent in the treatment of patients with de novo native coronary artery lesions:: 5-year results of the RAVEL trial

被引：0
|
作者：
Morice, M. C.
机构：
来源：
HERZ | 2006年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：705 / 705
页数：1
相关论文
共 50 条
  • [31] SPIRIT II STUDY: EVALUATION OF THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 5-YEAR RESULTS
    Onuma, Yoshinobu
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1827 - E1827
  • [32] 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Garg, Scot
    Vranckx, Pascal
    De Bruyne, Bernard
    Morice, Marie-Claude
    Colombo, Antonio
    Macaya, Carlos
    Richardt, Gert
    Fajadet, Jean
    Hamm, Christian
    Schuijer, Monique
    Rademaker, Tessa
    Wittebols, Kristel
    Stoll, Hans Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) : 1093 - 1101
  • [33] The Canadian multicenter, randomized, double-blind trial of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (C-SIRIUS): 365 day complete clinical follow-up
    Schampaert, E
    CIRCULATION, 2003, 108 (17) : 703 - 704
  • [34] Efficacy and safety at 3 years of the sirolimus-eluting stent to treat de novo long coronary artery lesions in the Canadian multicenter, randomized, double-blind trial C-SIRIUS
    Schampaert, E
    Cohen, EA
    Palisaitis, DA
    Traboulsi, MD
    Title, LM
    O'Neill, BJ
    Raco, D
    Mildenberger, RR
    Roy, L
    Plante, S
    CIRCULATION, 2005, 112 (17) : U714 - U714
  • [35] The US multicenter, randomized, double-blind study of the Sirolimus-eluting stent in coronary lesions: Early (30-day) safety results
    Moses, JW
    Leon, MB
    Popma, JJ
    Kuntz, RE
    CIRCULATION, 2001, 104 (17) : 464 - 464
  • [36] Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients
    Sinning, Jan-Malte
    Baumgart, Dietrich
    Werner, Nikos
    Klauss, Volker
    Baer, Frank M.
    Hartmann, Franz
    Drexler, Helmut
    Motz, Wolfgang
    Klues, Heinrich
    Voelker, Wolfram
    Pfannebecker, Thomas
    Stoll, Hans-Peter
    Nickenig, Georg
    AMERICAN HEART JOURNAL, 2012, 163 (03) : 446 - U397
  • [37] A randomized trial of the endeavor drug (ABT-578) eluting stent system versus the cypher sirolimus-eluting coronary stent system in De Novo native coronary artery lesions: Thirty-day results
    Kandzari, DE
    O'Shaughnessy, C
    Ball, M
    Turco, M
    Midei, M
    Applegate, R
    Kuntz, RE
    Fitzgerald, P
    Milstein, A
    Popma, JJ
    Leon, MB
    CIRCULATION, 2004, 110 (17) : 564 - 564
  • [38] Sirolimus-eluting heparin-coated cobalt chromium stent in the treatment of patients with De Novo native coronary artery lesions in small vessels - Final results of the EVOLUTION study
    Sousa, JE
    Abizaid, AS
    Abizaid, A
    Neumann, F
    Horstkotte, D
    Shen, CN
    Verheye, S
    Hayashi, EB
    Mehran, R
    Lansky, A
    Sousa, A
    Feres, F
    Mogg, M
    Sikand, R
    Fitzgerald, P
    Leon, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 88A - 88A
  • [39] The US multicenter, randomized, double-blind study of the sirolimus-eluting stent in coronary lesions: safety outcomes at 9 months
    Moses, JW
    O'Shaughnessy, C
    Caputo, R
    Kereiakes, D
    Brown, C
    Williams, D
    Kuntz, RE
    Leon, MB
    EUROPEAN HEART JOURNAL, 2002, 23 : 264 - 264
  • [40] A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-Eluting Stent in the Treatment of Subjects With up to 2 De Novo Coronary Artery Lesions-BIOFLOW IV: 5-Year Clinical Results
    Witzenbichler, Bernhard
    Slagboom, Ton
    Toelg, Ralph
    Haude, Michael
    Masotti, Monica
    Ruiz-Salmeron, Rafael
    Witkowski, Adam
    Waksman, Ron
    Saito, Shigeru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B113 - B114
12345